Tibolone is on the Pakistan Menopause Society's list of menopause medicines sold in Pakistan, under more than one brand, so there is a fair chance a doctor, a pharmacist or a relative will mention it. It is not the same as the HRT most leaflets describe, and it is worth knowing how it differs.
Tibolone
A synthetic hormone that works a little like combined HRT with a testosterone effect, and is on sale in Pakistan under more than one brand. What it is, who it is meant for, and what to ask your doctor.
The words and the guidance
- English
- Tibolone
- Urdu
- ٹیبولون
- Roman Urdu
- tibolone
- The NHS website describes tibolone as a type of HRT containing a synthetic hormone, which the body breaks down into substances that work in a similar way to estrogen, progesterone and testosterone.
- The NHS website says it is only suitable once your last period was more than a year ago, unless your ovaries have been removed or you take certain medicines that lower hormone levels.
- The Pakistan Menopause Society's 2026 recommendations describe tibolone as acting like estrogen in the brain, vagina and bone while having little or the opposite effect on the womb lining (section 5.6).
- The Australasian Menopause Society says tibolone is less effective than combined HRT for hot flushes, is not recommended after breast cancer, and calls for caution in women over 60 because the risk of stroke may be higher.
What it is
Tibolone is a tablet containing a synthetic hormone. The NHS website explains that the body breaks it down into substances that work in a similar way to three hormones at once: estrogen, progesterone and testosterone. The NHS website's page on types of HRT puts it simply: similar to combined HRT, with a testosterone effect as well.
The Pakistan Menopause Society calls it a STEAR, a selective tissue estrogenic activity regulator. Its recommendations describe tibolone acting like estrogen in the brain, vagina and bones, while having little or the opposite effect on the womb lining (5.6). On the breast, the Australasian Menopause Society says the evidence is mixed: a review of four trials found no significant increase, while large population studies found more breast cancer among current users of HRT, tibolone included. It says the long-term effect is not yet known.
Why it happens
Ordinary estrogen needs a progestogen beside it in a woman who still has her womb, to protect the lining (5.4). Because of how tibolone acts on the lining, the PMS recommendations say it generally does not need one added (5.6).
The timing matters. The NHS website says tibolone is only suitable once your last period was more than a year ago, which is the stage called postmenopause. The PMS recommendations place it in the same stage on their chart for choosing a regimen, for women over 54 or a year past their last period, and only after the risks have been explained carefully (Figure 2).
What the guidance lists
According to the NHS website, tibolone can help with:
- hot flushes
- low mood
- vaginal dryness or irritation
- keeping bones from thinning after the menopause, for which it can also be prescribed
The PMS recommendations add that it causes less bleeding from the womb and may improve mood and libido (5.6).
The NHS website lists stomach pain, breast tenderness and vaginal irritation as common side effects, which usually settle in the first few months. It says tibolone can take up to three months to work fully.
What the guidelines say about treatment
The PMS recommendations list tibolone among the HRT regimens, as a synthetic steroid alternative (5.3). For hot flushes, their first-line medicine is conventional HRT in women who are eligible and have no reason not to take it (7.1.1).
The NHS website also says some studies have suggested tibolone may not be as effective as combined HRT, because it may not raise estrogen levels as much. The Australasian Menopause Society says the same of hot flushes.
Whether tibolone suits you depends on your age, how long it has been since your last period, and your own and your family's health history. The risks and benefits of HRT are part of that conversation, and it is one to have with the doctor who would prescribe it, not with a pharmacy counter.
Available in Pakistan?
Yes. The Pakistan Menopause Society's 2026 list of menopause hormone products available in Pakistan (Table 10) includes tibolone tablets, sold under more than one brand.
When to see a doctor
If you are taking tibolone that was not prescribed for you, or was prescribed some time ago and never reviewed, book an appointment. Women's Health Concern, which counts tibolone among the types of HRT, says anyone on HRT should be reassessed by their doctor at least once a year.
See a doctor promptly about any unexpected bleeding. NICE NG23 says bleeding is a common side effect in the first six months of HRT, and in the three months after any change of dose or preparation, and is asked about at the three-month review. Unscheduled bleeding outside those times needs prompt medical help (1.8.4). The Australasian Menopause Society says slight bleeding or spotting is common when tibolone is started and tends to settle within a few months. More on that in bleeding after menopause.
Questions to ask your doctor
- Am I far enough past my last period for tibolone to be an option?
- Why tibolone for me, rather than combined HRT?
- Is there anything in my own or my family's history that would rule it out?
- What should I do if I get bleeding while I am taking it?
- How long would I take it, and when would we review it?
Faith and family
Medicines get shared in families with the best intentions. A sister's tablets, a mother's leftover strip. Tibolone is a hormone, and the NHS website says it is only suitable for some women and at some stages, which is why a prescription in your own name, after a doctor has asked about your history, matters more here than with most things in the medicine cabinet.
Track it
- Roshara's symptom score rates 27 symptoms in a few minutes, with no account. The total is something to take to your appointment. Take the symptom score
- Where am I? names the stage you might be in. Six questions. Take Where am I?
- Log it day by day in the tracker, with what came just before. It needs a free account. Open the tracker
Common questions
- Is tibolone HRT?
- The NHS website calls it a type of HRT. It is a single synthetic hormone rather than estrogen and a progestogen, which is why the Pakistan Menopause Society lists it separately as a synthetic steroid alternative (5.3). (Source: Pakistan Menopause Society, Good Clinical Practice Recommendations for Menopause Care in Pakistan (JSOGP 16(2), 28 April 2026))
- Is tibolone as effective as combined HRT?
- The NHS website says some studies have suggested it may not be as effective as combined HRT, because it may not raise estrogen levels as much. (Source: NHS website, About tibolone (reviewed 5 January 2023, review was due 5 January 2026))
- Can I take tibolone while I still have periods?
- The NHS website says it is only suitable if your last period was more than a year ago. The exceptions it names are women whose ovaries have been removed and women taking medicines called gonadorelin analogues. (Source: NHS website, About tibolone (reviewed 5 January 2023, review was due 5 January 2026))
- Does tibolone raise the risk of blood clots?
- The European Menopause and Andropause Society (EMAS) says tibolone, unlike raloxifene, is not linked with a higher risk of clots. The Australasian Menopause Society reports a review that found no difference in clots between tibolone and a dummy tablet (placebo). (Source: European Menopause and Andropause Society, Menopause Essentials 2026: Risk of venous thromboembolism (July 2026))
Sources
- NHS website, About tibolone (reviewed 5 January 2023, review was due 5 January 2026)Section: About tibolone; Key facts · Opened 1 October 2026
- Women's Health Concern, HRT: benefits and risks (factsheet, reviewed July 2026)Section: Types of HRT available; Summary · Opened 1 October 2026
- NHS website, Types of hormone replacement therapy (HRT) (reviewed 9 March 2023)Section: Tibolone · Opened 1 October 2026
- Pakistan Menopause Society, Good Clinical Practice Recommendations for Menopause Care in Pakistan (JSOGP 16(2), 28 April 2026)Section: 5.3; 5.4; 5.6; Figure 2; Table 8; 7.1.1; Table 10 · Opened 1 October 2026
- NICE NG23, Menopause: identification and management (last updated 15 April 2026)Section: 1.8.4 · Opened 10 October 2026
- Australasian Menopause Society, Tibolone as menopausal hormone therapy (information sheet, September 2023)Section: Key points; How effective is tibolone?; Side effects; Long term safety of tibolone · Opened 10 October 2026
- European Menopause and Andropause Society, Menopause Essentials 2026: Risk of venous thromboembolism (July 2026)Section: Menopausal hormone therapy (MHT) for women with VTE · Opened 15 October 2026